PortfoliosLab logoPortfoliosLab logo
IAK vs. IHE
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

IAK vs. IHE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in iShares U.S. Insurance ETF (IAK) and iShares U.S. Pharmaceuticals ETF (IHE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, IAK achieves a -3.71% return, which is significantly lower than IHE's 5.25% return. Over the past 10 years, IAK has outperformed IHE with an annualized return of 11.76%, while IHE has yielded a comparatively lower 7.69% annualized return.


IAK

1D
0.76%
1M
-2.20%
YTD
-3.71%
6M
-1.09%
1Y
-3.43%
3Y*
17.08%
5Y*
11.73%
10Y*
11.76%

IHE

1D
-1.44%
1M
1.13%
YTD
5.25%
6M
7.86%
1Y
38.69%
3Y*
17.02%
5Y*
9.73%
10Y*
7.69%
*Multi-year figures are annualized to reflect compound growth (CAGR)

IAK vs. IHE - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
IAK
iShares U.S. Insurance ETF
-3.71%9.50%28.25%11.28%11.33%26.84%-2.86%25.94%-11.48%14.18%
IHE
iShares U.S. Pharmaceuticals ETF
5.25%31.69%8.13%1.06%-4.87%13.07%13.66%15.47%-7.76%10.64%

Correlation

The correlation between IAK and IHE is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.17

Correlation (3Y)
Calculated over the trailing 3-year period

0.33

Correlation (5Y)
Calculated over the trailing 5-year period

0.42

Correlation (10Y)
Calculated over the trailing 10-year period

0.44

Correlation (All Time)
Calculated using the full available price history since May 8, 2006

0.54

Over the past year, the correlation between IAK and IHE has dropped to 0.17 - well below their long-term average of 0.54, suggesting their price drivers have been diverging.

IAK vs. IHE - Sectors Allocation Comparison


Sectors
IAK
IHE

Financial Services

99.5%

-

Healthcare

0.5%
100.0%

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Financial Services

IAK
99.5%
IHE

-

Healthcare

IAK
0.5%
IHE
100.0%

Basic Materials

IAK

-

IHE

-

Communication Services

IAK

-

IHE

-

Consumer Cyclical

IAK

-

IHE

-

Consumer Defensive

IAK

-

IHE

-

Energy

IAK

-

IHE

-

Industrials

IAK

-

IHE

-

Real Estate

IAK

-

IHE

-

Technology

IAK

-

IHE

-

Utilities

IAK

-

IHE

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IAK vs. IHE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IAK
IAK Risk / Return Rank: 66
Overall Rank
IAK Sharpe Ratio Rank: 77
Sharpe Ratio Rank
IAK Sortino Ratio Rank: 66
Sortino Ratio Rank
IAK Omega Ratio Rank: 66
Omega Ratio Rank
IAK Calmar Ratio Rank: 55
Calmar Ratio Rank
IAK Martin Ratio Rank: 55
Martin Ratio Rank

IHE
IHE Risk / Return Rank: 7272
Overall Rank
IHE Sharpe Ratio Rank: 6868
Sharpe Ratio Rank
IHE Sortino Ratio Rank: 7373
Sortino Ratio Rank
IHE Omega Ratio Rank: 6464
Omega Ratio Rank
IHE Calmar Ratio Rank: 8585
Calmar Ratio Rank
IHE Martin Ratio Rank: 7373
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IAK vs. IHE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares U.S. Insurance ETF (IAK) and iShares U.S. Pharmaceuticals ETF (IHE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


IAKIHEDifference

Sharpe ratio

Return per unit of total volatility

-0.23

2.28

-2.51

Sortino ratio

Return per unit of downside risk

-0.22

3.33

-3.55

Omega ratio

Gain probability vs. loss probability

0.97

1.39

-0.42

Calmar ratio

Return relative to maximum drawdown

-0.33

4.65

-4.98

Martin ratio

Return relative to average drawdown

-0.67

14.05

-14.73

IAK vs. IHE - Sharpe Ratio Comparison

The current IAK Sharpe Ratio is -0.23, which is lower than the IHE Sharpe Ratio of 2.28. The chart below compares the historical Sharpe Ratios of IAK and IHE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


IAKIHEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.23

2.28

-2.51

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.65

0.60

+0.05

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.56

0.43

+0.14

Sharpe Ratio (All Time)

Calculated using the full available price history

0.26

0.50

-0.24

Drawdowns

IAK vs. IHE - Drawdown Comparison

The maximum IAK drawdown since its inception was -77.38%, which is greater than IHE's maximum drawdown of -38.20%. Use the drawdown chart below to compare losses from any high point for IAK and IHE.


Loading charts...

Drawdown Indicators


IAKIHEDifference

Max Drawdown

Largest peak-to-trough decline

-77.38%

-38.20%

-39.18%

Max Drawdown (1Y)

Largest decline over 1 year

-7.98%

-8.47%

+0.49%

Max Drawdown (3Y)

Largest decline over 3 years

-11.58%

-15.92%

+4.34%

Max Drawdown (5Y)

Largest decline over 5 years

-14.76%

-16.03%

+1.27%

Max Drawdown (10Y)

Largest decline over 10 years

-44.95%

-29.59%

-15.36%

Current Drawdown

Current decline from peak

-4.98%

-3.91%

-1.07%

Average Drawdown

Average peak-to-trough decline

-16.14%

-7.92%

-8.22%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.01%

2.80%

+1.21%

Volatility

IAK vs. IHE - Volatility Comparison

The current volatility for iShares U.S. Insurance ETF (IAK) is 3.80%, while iShares U.S. Pharmaceuticals ETF (IHE) has a volatility of 5.43%. This indicates that IAK experiences smaller price fluctuations and is considered to be less risky than IHE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


IAKIHEDifference

Volatility (1M)

Calculated over the trailing 1-month period

3.80%

5.43%

-1.63%

Volatility (6M)

Calculated over the trailing 6-month period

9.98%

12.51%

-2.53%

Volatility (1Y)

Calculated over the trailing 1-year period

14.76%

17.05%

-2.29%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

18.07%

16.23%

+1.84%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

20.89%

18.05%

+2.84%

IAK vs. IHE - Expense Ratio Comparison

IAK has a 0.43% expense ratio, which is higher than IHE's 0.42% expense ratio.


Dividends

IAK vs. IHE - Dividend Comparison

IAK's dividend yield for the trailing twelve months is around 2.73%, more than IHE's 1.67% yield.


PositionTTM20252024202320222021202020192018201720162015
IAK
iShares U.S. Insurance ETF
2.73%1.69%1.49%1.44%1.69%2.26%2.07%1.84%2.33%1.62%1.68%1.62%
IHE
iShares U.S. Pharmaceuticals ETF
1.67%1.76%1.73%1.39%2.01%1.49%1.19%1.40%1.25%1.36%0.92%1.93%

Frequently Asked Questions


IAK and IHE have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

IHE has higher volatility (5.43%) compared to IAK (3.80%). In terms of maximum drawdown, IAK dropped -77.38% vs IHE's -38.20%.

On 10-year performance, IAK leads with 11.76% vs 7.69% for IHE. On fees, IHE is cheaper at 0.42% per year. On volatility, IAK has been the lower-risk option at 3.80%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, IAK has performed better with a 11.76% return vs 7.69%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

IHE is cheaper with a 0.42% expense ratio, compared with 0.43% for IAK.

IAK has the higher dividend yield at 2.73%, compared with 1.67% for IHE.

IAK is categorized as Financials Equities, while IHE is Health & Biotech Equities. IAK tracks Dow Jones U.S. Select Insurance Index, while IHE tracks Dow Jones U.S. Select Pharmaceuticals Index. Their fees differ too: 0.43% for IAK and 0.42% for IHE.

IHE currently has the higher Sharpe Ratio (2.28 vs -0.23), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for IAK and IHE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer